Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ATRAAtara Biotherapeutics, Inc.

Nasdaq · CIK 0001604464
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts422

Identity from submissions API

NameAtara Biotherapeutics, Inc.
CIK0001604464
TickersATRA
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN460920988
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone805-623-4211
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
1280 RANCHO CONEJO BLVD
THOUSAND OAKS
CA
91320
CA
Mailing address
1280 RANCHO CONEJO BLVD
THOUSAND OAKS
CA
91320
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1136 filing rows loaded from submissions recent; extra archives: CIK0001604464-submissions-001.json (136 filings, 2014-04-10 to 2015-08-04).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-18 4 FORM 4 0000905148-26-005037 5221
2026-11-17 144 xsl144X01/primary_doc.xml 0000905148-26-005017 001-36548 261567916 33 5342
2026-11-16 144 xsl144X01/primary_doc.xml 0000905148-26-004975 001-36548 261562789 33 5971
2026-11-10 S-3 S-3 0001104659-26-125314 333-299967 261541346 33 1044632 1 1
2026-11-10 10-Q 10-Q 0001104659-26-125192 001-36548 261540564 34 8498067 1 1
2026-11-10 8-K 8-K 2.02,9.01 0001104659-26-125171 001-36548 261540440 34 379040 1 1
2026-09-04 4 FORM 4 0000905148-26-004085 10910
2026-08-26 144 xsl144X01/primary_doc.xml 0000905148-26-003961 001-36548 261324621 33 5933
2026-08-26 4 FORM 4 0000905148-26-003960 11650
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-005481 005-88393 261281296 34 12369
2026-08-12 10-Q 10-Q 0001193125-26-346885 001-36548 261267689 34 10978557 1 1
2026-08-12 8-K 8-K 2.02 0001193125-26-346857 001-36548 261267565 34 455899 1 1
2026-07-24 4 OWNERSHIP DOCUMENT 0001104659-26-086733 22729
2026-07-24 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-086728 005-88393 261202619 34 16170
2026-07-06 3 FORM 3 0000905148-26-003168 3107
2026-06-26 8-K 8-K 5.02 0001193125-26-285498 001-36548 261129394 34 150222 1 1
2026-06-15 4 FORM 4 0000905148-26-002951 4754
2026-06-15 3 FORM 3 0000905148-26-002950 9813
2026-06-12 S-8 REGISTRATION STATEMENT 0001213900-26-068286 333-296747 261087056 33 208784 1 1
2026-06-12 8-K CURRENT REPORT 5.02,5.07 0001213900-26-068264 001-36548 261086605 34 213746 1 1
2026-06-11 4 FORM 4 0000905148-26-002921 4834
2026-06-11 4 FORM 4 0000905148-26-002920 4789
2026-06-11 4 FORM 4 0000905148-26-002919 13754
2026-05-20 4 xslF345X06/form4.xml 0000905148-26-002571 5223
2026-05-20 4 xslF345X06/form4.xml 0000905148-26-002570 5190
2026-05-18 144 xsl144X01/primary_doc.xml 0000905148-26-002507 001-36548 26994311 33 5951
2026-05-18 144 xsl144X01/primary_doc.xml 0000905148-26-002506 001-36548 26994299 33 5906
2026-05-14 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-061506 005-88393 26981652 34 15768
2026-05-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-002914 005-88393 26971199 34 15792
2026-05-12 424B5 424B5 0001193125-26-219518 333-275256 26968909 33 115953
2026-05-12 10-Q 10-Q 0001193125-26-219482 001-36548 26968764 34 17120142 1 1
2026-05-12 8-K 8-K 9.01 0001193125-26-219420 001-36548 26968570 34 383697 1 1
2026-05-11 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-217389 005-88393 26964985 34 14592
2026-05-11 4 4 0001193125-26-217380 8829
2026-05-11 4 xslF345X06/ownership.xml 0000935836-26-000239 6936
2026-05-11 3 xslF345X06/ownership.xml 0000935836-26-000238 5273
2026-05-08 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-002802 005-88393 26958415 34 17484
2026-05-07 144 xsl144X01/primary_doc.xml 0001193125-26-212781 001-36548 26955648 33 4714
2026-05-07 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000935836-26-000230 005-88393 26955518 34 16606
2026-05-07 8-K 8-K 8.01 0001193125-26-210413 001-36548 26950977 34 165285 1 1
2026-05-01 8-K 8-K 3.01 0001193125-26-201397 001-36548 26932411 34 150832 1 1
2026-04-24 DEF 14A DEF 14A 0001193125-26-177285 001-36548 26894161 34 3096832 1 1
2026-04-24 DEFA14A DEFA14A 0001193125-26-177280 001-36548 26894133 34 2019164
2026-03-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000930 333-294377 26794177 33 1752
2026-03-25 424B3 424B3 0001193125-26-124322 333-294377 26793430 33 134527
2026-03-23 CORRESP filename1.htm 0001193125-26-119715 7425
2026-03-20 UPLOAD filename1.pdf 0000000000-26-002840 333-294377 40132
2026-03-19 4 4 0001193125-26-116060 12481
2026-03-17 S-3 S-3 0001193125-26-110849 333-294377 26762176 33 338674 1 1
2026-03-16 424B5 424B5 0001193125-26-108386 333-275256 26757023 33 115937
2026-03-16 10-K 10-K 0001193125-26-108361 001-36548 26756876 34 14771437 1 1
2026-03-16 8-K 8-K 2.02,9.01 0001193125-26-108344 001-36548 26756777 34 397845 1 1
2026-03-12 8-K 8-K 8.01,9.01 0001193125-26-103127 001-36548 26745735 34 165546 1 1
2026-03-11 4 xslF345X05/form4.xml 0000905148-26-001225 5150
2026-03-11 4 xslF345X05/form4.xml 0000905148-26-001224 5117
2026-03-04 4 xslF345X05/form4.xml 0000905148-26-001144 9413
2026-03-04 4 xslF345X05/form4.xml 0000905148-26-001143 9254
2026-03-03 8-K 8-K 8.01,9.01 0001193125-26-086793 001-36548 26711140 34 144608 1 1
2026-03-02 144 xsl144X01/primary_doc.xml 0000905148-26-001102 001-36548 26710061 33 5328
2026-03-02 144 xsl144X01/primary_doc.xml 0000905148-26-001100 001-36548 26710055 33 5277
2026-02-23 8-K 8-K 1.01,3.02,8.01,9.01 0001193125-26-062534 001-36548 26662171 34 283873 1 1
2026-01-14 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-26-013362 005-88393 26534569 34 17009
2026-01-14 4 4 0001193125-26-013358 8475
2026-01-12 144 xsl144X01/primary_doc.xml 0001193125-26-010883 001-36548 26528281 33 6159
2026-01-12 8-K 8-K 2.02,8.01,9.01 0001193125-26-010342 001-36548 26526663 34 155559 1 1
2026-01-02 8-K 8-K 1.01,9.01 0001193125-26-000907 001-36548 26502310 34 150496 1 1
2025-12-01 4 4 0001193125-25-304018 12399
2025-11-19 4 xslF345X05/form4.xml 0000905148-25-004141 6377
2025-11-19 4 xslF345X05/form4.xml 0000905148-25-004140 7787
2025-11-17 144 xsl144X01/primary_doc.xml 0000905148-25-004102 001-36548 251492266 33 4797
2025-11-17 144 xsl144X01/primary_doc.xml 0000905148-25-004101 001-36548 251492256 33 4754
2025-11-14 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-112574 005-88393 251486661 34 36205
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000703 005-88393 251485837 34 16577
2025-11-12 10-Q 10-Q 0001193125-25-276219 001-36548 251469626 34 12182027 1 1
2025-11-12 8-K 8-K 2.02,9.01 0001193125-25-276209 001-36548 251469583 34 228931 1 1
2025-10-07 8-K 8-K 2.05 0001193125-25-232117 001-36548 251377764 34 132349 1 1
2025-09-04 8-K 8-K 5.02 0000950170-25-112898 001-36548 251291336 34 142600 1 1
2025-08-20 4 xslF345X05/form4.xml 0000905148-25-003070 7819
2025-08-20 4 xslF345X05/form4.xml 0000905148-25-003069 7785
2025-08-19 4 4 0000950170-25-110310 7612
2025-08-19 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-110311 005-88393 251233576 34 17258
2025-08-18 144 xsl144X01/primary_doc.xml 0000905148-25-003038 001-36548 251228523 33 4798
2025-08-18 144 xsl144X01/primary_doc.xml 0000905148-25-003037 001-36548 251228481 33 4754
2025-08-11 10-Q 10-Q 0000950170-25-106550 001-36548 251202089 34 11343647 1 1
2025-08-11 8-K 8-K 2.02,9.01 0000950170-25-106533 001-36548 251201971 34 432245 1 1
2025-07-21 4 4 0000950170-25-097087 7101
2025-07-14 8-K 8-K 2.02,8.01,9.01 0001193125-25-158719 001-36548 251121768 34 159899 1 1
2025-06-12 4 xslF345X05/form4.xml 0000905148-25-002142 4636
2025-06-12 4 xslF345X05/form4.xml 0000905148-25-002141 4663
2025-06-12 4 xslF345X05/form4.xml 0000905148-25-002140 4519
2025-06-12 4 xslF345X05/form4.xml 0000905148-25-002139 4707
2025-06-12 4 xslF345X05/form4.xml 0000905148-25-002138 4645
2025-06-12 4 xslF345X05/form4.xml 0000905148-25-002137 4667
2025-06-11 8-K 8-K 5.07 0001193125-25-139150 001-36548 251040178 34 145959 1 1
2025-05-23 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-052422 005-88393 25982130 34 37845
2025-05-23 3 OWNERSHIP DOCUMENT 0001104659-25-052410 3432
2025-05-23 3 OWNERSHIP DOCUMENT 0001104659-25-052406 12349
2025-05-21 3 3 0000950170-25-075902 8242
2025-05-21 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-075903 005-88393 25974238 34 40385
2025-05-20 4 xslF345X05/form4.xml 0000905148-25-001866 4913
2025-05-20 4 xslF345X05/form4.xml 0000905148-25-001865 4945
2025-05-16 144 xsl144X01/primary_doc.xml 0000905148-25-001838 001-36548 25961135 33 4797
2025-05-16 144 xsl144X01/primary_doc.xml 0000905148-25-001837 001-36548 25961128 33 4750
2025-05-16 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-050119 005-88393 25961048 34 20011
2025-05-16 4 OWNERSHIP DOCUMENT 0001104659-25-050116 13719
2025-05-16 8-K 8-K 8.01,9.01 0001193125-25-121824 001-36548 25960705 34 625228 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-049700 005-88393 25956714 34 21759
2025-05-15 424B5 424B5 0001193125-25-120939 333-275256 25955774 33 1122425
2025-05-15 10-Q 10-Q 0000950170-25-072040 001-36548 25949002 34 10596299 1 1
2025-05-15 8-K 8-K 2.02,5.02,9.01 0001193125-25-120345 001-36548 25948980 34 233544 1 1
2025-05-12 8-K 8-K 2.05 0000950170-25-069198 001-36548 25934876 34 149743 1 1
2025-05-06 8-K 8-K 8.01,9.01 0001193125-25-113811 001-36548 25917186 34 162023 1 1
2025-04-28 DEFA14A DEFA14A 0000950170-25-059333 001-36548 25880666 34 288857
2025-04-28 DEF 14A DEF 14A 0000950170-25-059322 001-36548 25880541 34 4790854 1 1
2025-04-10 3 xslF345X02/form3.xml 0000905148-25-001196 18830
2025-04-04 8-K 8-K 1.01 0000950170-25-051121 001-36548 25814660 34 149689 1 1
2025-04-02 4 xslF345X05/form4.xml 0000905148-25-001058 24643
2025-03-31 8-K 8-K 5.02 0001193125-25-068789 001-36548 25793684 34 142672 1 1
2025-03-07 10-K 10-K 0000950170-25-035507 001-36548 25720159 34 14447101 1 1
2025-03-07 8-K 8-K 2.02,9.01 0000950170-25-035482 001-36548 25719974 34 464167 1 1
2025-03-05 4 xslF345X05/form4.xml 0000905148-25-000865 4936
2025-03-05 4 xslF345X05/form4.xml 0000905148-25-000864 4909
2025-03-05 4 xslF345X05/form4.xml 0000905148-25-000863 5097
2025-03-03 144 xsl144X01/primary_doc.xml 0000905148-25-000812 001-36548 25700587 33 4311
2025-03-03 144 xsl144X01/primary_doc.xml 0000905148-25-000811 001-36548 25700567 33 4272
2025-03-03 144 xsl144X01/primary_doc.xml 0000905148-25-000810 001-36548 25700557 33 4256
2025-03-03 8-K 8-K 2.05,9.01 0000950170-25-030832 001-36548 25697747 34 182386 1 1
2025-02-06 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-015605 005-88393 25598690 34 282304
2025-01-29 4 xslF345X05/form4.xml 0000905148-25-000245 5181
2025-01-27 8-K 8-K 2.05,9.01 0000950170-25-009225 001-36548 25559428 34 156819 1 1
2025-01-21 8-K 8-K 8.01,9.01 0000950170-25-006992 001-36548 25540437 34 181518 1 1
2025-01-17 S-8 S-8 0001193125-25-008413 333-284338 25538718 33 78678
2025-01-16 8-K 8-K 2.02,8.01,9.01 0000950170-25-006191 001-36548 25535763 34 196931 1 1
2024-12-23 8-K 8-K 5.03,9.01 0001193125-24-284167 001-36548 241573502 34 391277 1 1
2024-11-20 4 xslF345X05/form4.xml 0000905148-24-003243 4986
2024-11-20 4 xslF345X05/form4.xml 0000905148-24-003242 4989
2024-11-20 4 xslF345X05/form4.xml 0000905148-24-003241 5016
2024-11-18 144 xsl144X01/primary_doc.xml 0000905148-24-003232 001-36548 241472723 33 4892
2024-11-18 144 xsl144X01/primary_doc.xml 0000905148-24-003231 001-36548 241472704 33 4880
2024-11-18 144 xsl144X01/primary_doc.xml 0000905148-24-003230 001-36548 241472698 33 4858
2024-11-18 144 xsl144X01/primary_doc.xml 0000905148-24-003229 001-36548 241472681 33 4836
2024-11-14 SC 13G/A atra13ga1.htm 0000935836-24-000720 005-88393 241464902 34 48376
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-118959 005-88393 241462652 34 136670
2024-11-12 10-Q 10-Q 0000950170-24-125389 001-36548 241448177 34 8630481 1 1
2024-11-12 8-K 8-K 2.02,5.02,9.01 0000950170-24-125334 001-36548 241447929 34 437151 1 1
2024-11-12 SC 13G/A UnitedStates_13G__AtaraBioth.txt 0000932471-24-000879 005-88393 241446550 34 6593
2024-11-04 SC 13G/A UnitedStates_13G__AtaraBioth.txt 0000932471-24-000340 005-88393 241421495 34 5654
2024-10-15 8-K 8-K 5.02 0001193125-24-237582 001-36548 241371891 34 145577 1 1
2024-09-13 SC 13G/A SC 13G/A 0001104659-24-099749 005-88393 241297670 34 92364
2024-09-11 4 xslF345X05/form4.xml 0000905148-24-002545 5239
2024-09-05 3 OWNERSHIP DOCUMENT 0001104659-24-097458 11681
2024-09-05 SC 13D/A SC 13D/A 0001104659-24-097369 005-88393 241281462 34 70618
2024-09-04 424B5 424B5 0001193125-24-213178 333-275256 241278113 33 644776
2024-09-03 8-K 8-K 5.02,8.01,9.01 0001193125-24-212168 001-36548 241274902 34 494620 1 1
2024-08-20 4 xslF345X05/form4.xml 0000905148-24-002306 6664
2024-08-20 4 xslF345X05/form4.xml 0000905148-24-002305 8038
2024-08-20 4 xslF345X05/form4.xml 0000905148-24-002304 8164
2024-08-20 4 xslF345X05/form4.xml 0000905148-24-002303 6587
2024-08-20 4 xslF345X05/form4.xml 0000905148-24-002302 6697
2024-08-16 144 xsl144X01/primary_doc.xml 0000905148-24-002274 001-36548 241216819 33 4937
2024-08-16 144 xsl144X01/primary_doc.xml 0000905148-24-002273 001-36548 241216797 33 4841
2024-08-16 144 xsl144X01/primary_doc.xml 0000905148-24-002272 001-36548 241216783 33 4877
2024-08-16 144 xsl144X01/primary_doc.xml 0000905148-24-002271 001-36548 241216768 33 4861
2024-08-16 144 xsl144X01/primary_doc.xml 0000905148-24-002270 001-36548 241216739 33 4840
2024-08-14 4 xslF345X05/form4.xml 0000905148-24-002244 10121
2024-08-12 10-Q 10-Q 0000950170-24-095533 001-36548 241197877 34 8368837 1 1
2024-08-12 8-K 8-K 2.02,5.02,9.01 0000950170-24-095526 001-36548 241197820 34 786247 1 1
2024-07-17 8-K 8-K 8.01,9.01 0001193125-24-180371 001-36548 241122414 34 166172 1 1
2024-07-08 SC 13G/A us0465131078_070824.txt 0001086364-24-008257 005-88393 241105237 34 12653
2024-06-20 8-K 8-K 3.03,5.03,9.01 0001193125-24-164554 001-36548 241057338 34 165555 1 1
2024-06-17 8-K 8-K 8.01,9.01 0001193125-24-162069 001-36548 241047020 34 162349 1 1
2024-06-11 S-8 S-8 0001193125-24-159220 333-280126 241036648 33 124912
2024-06-11 S-8 S-8 0001193125-24-159213 333-280125 241036609 33 212260
2024-06-11 8-K 8-K 5.07 0001193125-24-158461 001-36548 241033901 34 170044 1 1
2024-05-22 SC 13D SC 13D 0001104659-24-064358 005-88393 24974696 34 147000
2024-05-20 4 xslF345X05/form4.xml 0000905148-24-001561 5049
2024-05-20 4 xslF345X05/form4.xml 0000905148-24-001560 4981
2024-05-20 4 xslF345X05/form4.xml 0000905148-24-001559 5007
2024-05-20 4 xslF345X05/form4.xml 0000905148-24-001558 4971
2024-05-20 4 xslF345X05/form4.xml 0000905148-24-001557 4980
2024-05-16 144 xsl144X01/primary_doc.xml 0000905148-24-001501 001-36548 24957536 33 4939
2024-05-16 144 xsl144X01/primary_doc.xml 0000905148-24-001500 001-36548 24957528 33 4839
2024-05-16 144 xsl144X01/primary_doc.xml 0000905148-24-001499 001-36548 24957527 33 4873
2024-05-16 144 xsl144X01/primary_doc.xml 0000905148-24-001498 001-36548 24957526 33 4859
2024-05-16 144 xsl144X01/primary_doc.xml 0000905148-24-001497 001-36548 24957525 33 4836
2024-05-16 144 xsl144X01/primary_doc.xml 0000905148-24-001496 001-36548 24957497 33 16735
2024-05-10 DEFR14A DEFR14A 0001193125-24-136215 001-36548 24935451 34 19246
2024-05-09 10-Q 10-Q 0000950170-24-056959 001-36548 24930700 34 7707153 1 1
2024-05-09 8-K 8-K 2.02,9.01 0000950170-24-056901 001-36548 24930464 34 398537 1 1
2024-04-26 DEFA14A DEFA14A 0000950170-24-049170 001-36548 24884084 34 378506
2024-04-26 DEF 14A DEF 14A 0000950170-24-049147 001-36548 24883956 34 4803579 1 1
2024-04-12 PRE 14A PRE 14A 0000950170-24-044046 001-36548 24841645 34 3970920 1 1
2024-04-02 4 xslF345X05/form4.xml 0000905148-24-001060 4541
2024-04-02 4 xslF345X05/form4.xml 0000905148-24-001059 4543
2024-04-02 4 xslF345X05/form4.xml 0000905148-24-001058 4582
2024-04-02 4 xslF345X05/form4.xml 0000905148-24-001057 4795
2024-04-02 4 xslF345X05/form4.xml 0000905148-24-001056 4523
2024-03-29 8-K 8-K 5.02 0000950170-24-038690 001-36548 24804420 34 147547 1 1
2024-03-28 10-K 10-K 0000950170-24-037644 001-36548 24793778 34 14473722 1 1
2024-03-28 8-K 8-K 2.02,9.01 0000950170-24-037643 001-36548 24793716 34 456419 1 1
2024-03-18 SC 13G SC 13G 0001104659-24-035552 005-88393 24759173 34 145664
2024-03-06 4 xslF345X05/form4.xml 0000905148-24-000911 5050
2024-03-06 4 xslF345X05/form4.xml 0000905148-24-000910 4982
2024-03-06 4 xslF345X05/form4.xml 0000905148-24-000909 5008
2024-03-06 4 xslF345X05/form4.xml 0000905148-24-000908 6415
2024-03-06 4 xslF345X05/form4.xml 0000905148-24-000907 4980
2024-03-04 144 xsl144X01/primary_doc.xml 0000905148-24-000882 001-36548 24717810 33 16630
2024-03-04 144 xsl144X01/primary_doc.xml 0000905148-24-000881 001-36548 24717804 33 16522
2024-03-04 144 xsl144X01/primary_doc.xml 0000905148-24-000880 001-36548 24717801 33 16526
2024-03-04 144 xsl144X01/primary_doc.xml 0000905148-24-000879 001-36548 24717798 33 16526
2024-03-04 144 xsl144X01/primary_doc.xml 0000905148-24-000878 001-36548 24717786 33 16546
2024-02-23 8-K 8-K 5.02 0000950170-24-019416 001-36548 24671685 34 148488 1 1
2024-02-14 SC 13G/A SC 13G/A 0001193125-24-036542 005-88393 24640203 34 78496
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023785 005-88393 24638934 34 75951
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020351 005-88393 24627411 34 13120
2024-02-09 SC 13G/A atra224.txt 0000814133-24-000060 005-88393 24615349 34 4161
2024-02-06 SC 13G/A ATARA.txt 0000769993-24-000055 005-88393 24600889 34 23770
2024-01-26 SC 13G/A us0465131078_012624.txt 0001086364-24-004860 005-88393 24569157 34 13473
2024-01-22 SC 13G/A Atara_Bio_Inc.txt 0000093751-24-000070 005-88393 24548076 34 8510
2024-01-09 4 xslF345X05/form4.xml 0000905148-24-000115 5219
2024-01-09 4 xslF345X05/form4.xml 0000905148-24-000114 5150
2024-01-09 4 xslF345X05/form4.xml 0000905148-24-000113 5357
2024-01-09 4 xslF345X05/form4.xml 0000905148-24-000112 5140
2024-01-09 4 xslF345X05/form4.xml 0000905148-24-000111 5330
2024-01-09 424B5 424B5 0001193125-24-005223 333-275256 24523595 33 639930
2024-01-09 SC 13G/A NONE 0001567619-24-000004 005-88393 24523521 34 117125
2024-01-09 8-K 8-K 1.01,3.01,9.01 0001193125-24-005188 001-36548 24523230 34 482003 1 1
2024-01-08 8-K 8-K 2.05,5.02,7.01,8.01,9.01 0001193125-24-003945 001-36548 24518449 34 2888684 1 1
2024-01-03 S-8 S-8 0001193125-24-001495 333-276360 24506409 33 82542
2023-12-20 8-K 8-K 8.01,9.01 0000950170-23-071896 001-36548 231501659 34 177332 1 1
2023-12-07 SC 13G/A FILING ATARA BIOTHERAPEUTICS, INC. 0000019617-23-000584 005-88393 34 89931
2023-11-21 SC 13G atra13g.htm 0000935836-23-000715 005-88393 231424066 34 47967
2023-11-20 4 xslF345X05/form4.xml 0000905148-23-001513 4959
2023-11-20 4 xslF345X05/form4.xml 0000905148-23-001512 4891
2023-11-20 4 xslF345X05/form4.xml 0000905148-23-001511 4917
2023-11-20 4 xslF345X05/form4.xml 0000905148-23-001510 4884
2023-11-20 4 xslF345X05/form4.xml 0000905148-23-001509 4882
2023-11-20 4 xslF345X05/form4.xml 0000905148-23-001508 4890
2023-11-17 424B3 424B3 0001193125-23-279824 333-275256 231419252 33 190298
2023-11-15 4 xslF345X05/form4.xml 0000905148-23-001457 6319
2023-11-14 4 xslF345X05/form4.xml 0000905148-23-001450 4711
2023-11-14 4 xslF345X05/form4.xml 0000905148-23-001449 4701
2023-11-13 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-11-13 16:30:00 9999999995-23-003308 333-275256 231401274 33 1757
2023-11-09 8-K 8-K 8.01,9.01 0001193125-23-273808 001-36548 231389754 34 166917 1 1
2023-11-08 CORRESP filename1.htm 0001193125-23-273647 8110
2023-11-06 UPLOAD filename1.pdf 0000000000-23-012129 40323
2023-11-01 S-3 S-3 0001193125-23-268364 333-275256 231369284 33 658489
2023-11-01 8-K 8-K 8.01,9.01 0001193125-23-268185 001-36548 231368193 34 371549 1 1
2023-11-01 10-Q 10-Q 0000950170-23-057147 001-36548 231366701 34 10058635 1 1
2023-11-01 8-K 8-K 1.01,2.02,2.05,9.01 0000950170-23-057146 001-36548 231366686 34 506811 1 1
2023-09-20 8-K 8-K 8.01,9.01 0001193125-23-237762 001-36548 231264947 34 162139 1 1
2023-08-18 4 xslF345X05/form4.xml 0001140361-23-040564 6343
2023-08-18 4 xslF345X05/form4.xml 0001140361-23-040563 6555
2023-08-18 4 xslF345X05/form4.xml 0001140361-23-040562 6421
2023-08-18 4 xslF345X05/form4.xml 0001140361-23-040561 6357
2023-08-18 4 xslF345X05/form4.xml 0001140361-23-040560 6349
2023-08-18 4 xslF345X05/form4.xml 0001140361-23-040559 6355
2023-08-08 10-Q 10-Q 0000950170-23-039820 001-36548 231151458 34 10614474 1 1
2023-08-08 8-K 8-K 2.02,9.01 0000950170-23-039797 001-36548 231151284 34 559754 1 1
2023-06-29 4 xslF345X04/form4.xml 0001140361-23-032216 4561
2023-06-09 3 xslF345X02/form3.xml 0001140361-23-029142 18334
2023-06-09 3 xslF345X02/form3.xml 0001140361-23-029141 16705
2023-06-09 3 xslF345X02/form3.xml 0001140361-23-029143 23961
2023-06-09 8-K 8-K 5.02 0000950170-23-027257 001-36548 231005270 34 165540 1 1
2023-06-05 8-K 8-K 5.02,5.07 0000950170-23-026351 001-36548 23992479 34 205965 1 1
2023-06-02 4 xslF345X04/form4.xml 0001140361-23-028161 16777
2023-06-02 4 xslF345X04/form4.xml 0001140361-23-028154 13985
2023-06-02 4 xslF345X04/form4.xml 0001140361-23-028153 12085
2023-06-02 4 xslF345X04/form4.xml 0001140361-23-028152 12554
2023-06-02 4 xslF345X04/form4.xml 0001140361-23-028150 12164
2023-06-02 4 xslF345X04/form4.xml 0001140361-23-028151 12783
2023-06-02 4 xslF345X04/form4.xml 0001140361-23-028149 12556
2023-05-18 4 xslF345X04/form4.xml 0001140361-23-025560 6371
2023-05-18 4 xslF345X04/form4.xml 0001140361-23-025561 4945
2023-05-18 4 xslF345X04/form4.xml 0001140361-23-025559 4970
2023-05-18 4 xslF345X04/form4.xml 0001140361-23-025558 6336
2023-05-12 8-K 8-K 5.02 0000950170-23-021809 001-36548 23916352 34 165610 1 1
2023-05-08 10-Q 10-Q 0000950170-23-018820 001-36548 23897912 34 9618711 1 1
2023-05-08 8-K 8-K 2.02,5.02,9.01 0000950170-23-018793 001-36548 23897739 34 456693 1 1
2023-05-02 UPLOAD filename1.pdf 0000000000-23-004518 39783
2023-04-21 CORRESP filename1.htm 0001193125-23-110534 74128
2023-04-07 3 xslF345X02/form3.xml 0001140361-23-017346 21921
2023-04-07 DEFA14A DEFA14A 0000950170-23-012206 001-36548 23809054 34 4276819
2023-04-07 DEF 14A DEF 14A 0000950170-23-012204 001-36548 23809027 34 6300831 1 1
2023-03-31 8-K 8-K 5.02 0000950170-23-011416 001-36548 23788340 34 177402 1 1
2023-03-27 UPLOAD filename1.pdf 0000000000-23-003045 52277
2023-03-24 PRE 14A PRE 14A 0000950170-23-009724 001-36548 23759913 34 5520419 1 1
2023-03-10 8-K 8-K 7.01 0001193125-23-067628 001-36548 23723954 34 143023 1 1
2023-03-06 4 FORM 4 0001567619-23-004540 5167
2023-03-06 4 FORM 4 0001567619-23-004539 5166
2023-03-06 4 FORM 4 0001567619-23-004538 5168
2023-03-06 4 FORM 4 0001567619-23-004537 5147
2023-03-03 4 xslF345X03/form4.xml 0001140361-23-010102 7027
2023-03-03 4 xslF345X03/form4.xml 0001140361-23-010104 7002
2023-03-03 4 xslF345X03/form4.xml 0001140361-23-010100 6966
2023-03-03 4 xslF345X03/form4.xml 0001140361-23-010097 7164
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021653 005-88393 23629666 34 77505
2023-02-14 SC 13G/A SCHEDULE 13G/A, AMENDMENT #2 0000899140-23-000372 005-88393 23628855 34 70649
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-037206 005-88393 23622434 34 78782
2023-02-13 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-23-028807,2023-02-13 9999999995-23-000387 333-253731 23621657 33 1769
2023-02-09 4 FORM 4 0001567619-23-002174 4818
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015376 005-88393 23602468 34 13040
2023-02-09 SC 13G/A filing.txt 0000315066-23-001406 005-88393 23601268 34 8183
2023-02-09 POS AM POS AM 0001193125-23-028807 333-253731 23600729 33 537844
2023-02-09 S-8 S-8 0001193125-23-028606 333-269647 23600244 33 88230
2023-02-08 10-K 10-K 0000950170-23-002185 001-36548 23599828 34 17034348 1 1
2023-02-08 POSASR POSASR 0001193125-23-028491 333-253731 23599703 33 576175
2023-02-08 8-K 8-K 2.02,5.02,9.01 0000950170-23-002132 001-36548 23599023 34 589516 1 1
2023-02-08 SC 13G atra223.txt 0000814133-23-000032 005-88393 23598922 34 4025
2023-02-07 SC 13G ATARA_BIOTHERAPEUTICS.txt 0000769993-23-000046 005-88393 23591739 34 23544
2023-02-03 SC 13G Atara_Biotherapeutics_Inc.txt 0000093751-23-000187 005-88393 23585610 34 10416
2023-01-24 SC 13G/A us0465131078_012423.txt 0001306550-23-002917 005-88393 23547354 34 13471
2023-01-18 SC 13G/A FILING ATARA BIOTHERAPEUTICS, INC. 0000019617-23-000093 005-88393 34 89884
2023-01-06 8-K 8-K 2.03 0001193125-23-003555 001-36548 23515267 34 142450 1 1
2022-12-20 8-K 8-K 1.01 0001193125-22-309181 001-36548 221475351 34 145458 1 1
2022-12-19 8-K 8-K 5.02,8.01 0001193125-22-307898 001-36548 221469649 34 144583 1 1
2022-12-16 3 FORM 3 0001567619-22-021742 11387
2022-11-18 4 xslF345X03/form4.xml 0001140361-22-042381 11850
2022-11-18 4 xslF345X03/form4.xml 0001140361-22-042380 12588
2022-11-18 4 xslF345X03/form4.xml 0001140361-22-042379 12352
2022-11-18 4 xslF345X03/form4.xml 0001140361-22-042378 11912
2022-11-08 10-Q 10-Q 0000950170-22-023248 001-36548 221369201 34 11294022 1 1
2022-11-08 8-K 8-K 2.02,9.01 0000950170-22-023226 001-36548 221369056 34 657836 1 1
2022-09-28 8-K 8-K 1.01 0001193125-22-253304 001-36548 221276447 34 143202 1 1
2022-09-27 8-K 8-K 5.03,9.01 0001193125-22-252141 001-36548 221271150 34 382992 1 1
2022-08-18 4 FORM 4 0001140361-22-030302 4886
2022-08-18 4 FORM 4 0001140361-22-030300 4824
2022-08-18 4 FORM 4 0001140361-22-030299 6461
2022-08-18 4 FORM 4 0001140361-22-030297 4845
2022-08-08 10-Q 10-Q 0000950170-22-015536 001-36548 221144543 34 10415664 1 1
2022-08-08 8-K 8-K 1.01,2.02,2.05,5.02,9.01 0000950170-22-015519 001-36548 221144400 34 636367 1 1
2022-07-22 S-8 S-8 0001193125-22-200029 333-266288 221100038 33 190119
2022-06-29 4 FORM 4 0001567619-22-013481 4814
2022-06-27 4 FORM 4 0001140361-22-024166 6966
2022-06-27 4 FORM 4 0001140361-22-024165 6714
2022-06-27 4 FORM 4 0001140361-22-024164 6712
2022-06-27 4 FORM 4 0001140361-22-024163 6707
2022-06-27 4 FORM 4 0001140361-22-024162 6753
2022-06-27 4 FORM 4 0001140361-22-024161 6679
2022-06-27 4 FORM 4 0001140361-22-024160 6703
2022-06-27 4 FORM 4 0001140361-22-024159 6724
2022-06-27 4 FORM 4 0001140361-22-024158 10648
2022-06-24 8-K 8-K 5.07 0001193125-22-181461 001-36548 221039998 34 155366 1 1
2022-06-10 4 FORM 4 0001567619-22-012667 4991
2022-05-19 4 FORM 4 0001140361-22-019990 6298
2022-05-19 4 FORM 4 0001140361-22-019988 6297
2022-05-19 4 FORM 4 0001140361-22-019981 4837
2022-05-19 4 FORM 4 0001140361-22-019978 4899
2022-05-19 8-K 8-K 1.02 0001193125-22-155021 001-36548 22942833 34 149809 1 1
2022-05-05 10-Q 10-Q 0001564590-22-018253 001-36548 22896409 34 8360770 1 1
2022-05-05 8-K 8-K 2.02,9.01 0001564590-22-018241 001-36548 22896143 34 484870 1 1
2022-04-27 DEFA14A DEFA14A 0001564590-22-016099 001-36548 22860296 34 1565311
2022-04-27 DEF 14A DEF 14A 0001564590-22-016087 001-36548 22860124 34 3054602
2022-04-04 8-K 8-K 2.01,9.01 0001193125-22-095073 001-36548 22802107 34 623034 1 1
2022-03-11 SC 13G/A SC 13G/A 0001193125-22-073533 005-88393 22733964 34 79319
2022-03-03 4 FORM 4 0001140361-22-007767 10353
2022-03-03 4 FORM 4 0001140361-22-007765 8892
2022-03-03 4 FORM 4 0001140361-22-007766 6989
2022-03-03 4 FORM 4 0001140361-22-007764 8954
2022-03-03 4 FORM 4 0001140361-22-007763 10614
2022-02-28 S-8 FORM S-8 0001193125-22-058338 333-263109 22691707 33 79721
2022-02-28 10-K 10-K 0001564590-22-007633 001-36548 22690005 34 19012908 1 1
2022-02-28 8-K 8-K 2.02,9.01 0001564590-22-007610 001-36548 22689338 34 539170 1 1
2022-02-18 8-K 8-K 8.01 0001193125-22-046032 001-36548 22650882 34 147569 1 1
2022-02-15 SC 13G/A SC 13G/A 0001193125-22-042462 005-88393 22636150 34 79935
2022-02-14 4 FORM 4 0001567619-22-004499 8531
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-023132 005-88393 22634479 34 76583
2022-02-14 SC 13G/A SCHEDULE 13G (AMENDMENT NO. 1) 0000899140-22-000307 005-88393 22632823 34 63893
2022-02-09 SC 13G/A NONE 0001567619-22-003064 005-88393 22608263 34 117204
2022-02-09 4 FORM 4 0001567619-22-003052 5620
2022-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-22-016551 005-88393 22606517 34 13033
2022-02-09 SC 13G filing.txt 0000315066-22-000800 005-88393 22604072 34 8437
2022-02-03 SC 13G/A us0465131078_020322.txt 0000834237-22-006384 005-88393 22589133 34 13469
2022-01-26 8-K 8-K 1.01,2.02,5.02,9.01 0001193125-22-018422 001-36548 22558881 34 182586 1 1
2022-01-10 8-K 8-K 7.01,9.01 0001193125-22-005158 001-36548 22519846 34 7303522 1 1
2022-01-07 SC 13G/A FILING ATARA BIOTHERAPEUTICS, INC. 0000019617-22-000035 005-88393 34 89979
2022-01-05 4 FORM 4 0001567619-22-000568 8531
2021-12-21 SC 13G SCHEDULE 13G 0000899140-21-000770 005-88393 211510200 34 67268
2021-12-03 4 FORM 4 0001567619-21-021583 8925
2021-11-26 8-K 8-K 8.01,9.01 0001193125-21-341306 001-36548 211452292 34 356322 1 1
2021-11-26 424B5 424B5 0001193125-21-341305 333-253731 211452287 33 495589
2021-11-18 4 FORM 4 0001567619-21-020781 5432
2021-11-18 4 FORM 4 0001567619-21-020780 5428
2021-11-18 4 FORM 4 0001567619-21-020779 5435
2021-11-18 4 FORM 4 0001567619-21-020778 5434
2021-11-18 4 FORM 4 0001567619-21-020777 5416
2021-11-17 4 FORM 4 0001567619-21-020653 11036
2021-11-05 4 FORM 4 0001567619-21-019403 4672
2021-11-04 4 FORM 4 0001567619-21-019331 8529
2021-11-04 10-Q 10-Q 0001564590-21-054261 001-36548 211378126 34 7968810 1 1
2021-11-04 8-K 8-K 2.02,9.01 0001564590-21-054254 001-36548 211378084 34 537450 1 1
2021-10-04 8-K 8-K 1.01 0001193125-21-290388 001-36548 211301056 34 149884 1 1
2021-09-29 S-8 S-8 0001193125-21-286789 333-259882 211292009 33 184879
2021-09-24 4 FORM 4 0001567619-21-017578 10654
2021-09-17 4 FORM 4 0001567619-21-017260 5122
2021-08-31 4 FORM 4 0001567619-21-016517 4727
2021-08-19 4 FORM 4 0001567619-21-016151 5168
2021-08-19 4 FORM 4 0001567619-21-016150 5164
2021-08-19 4 FORM 4 0001567619-21-016149 5171
2021-08-19 4 FORM 4 0001567619-21-016148 5170

Latest XBRL company facts

One latest value per concept from companyfacts (422 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 10.19M 2026-11-06 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
dei EntityPublicFloat Entity Public Float USD 38.73M 2025-06-30 2025 FY 10-K 2026-03-16 0001193125-26-108361
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 789,045 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177285
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.04M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177285
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 22.06 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177285
ffd NetFeeAmt NetFeeAmt USD 0 2026-11-09 S-3 2026-11-10 0001104659-26-125314
ffd TtlFeeAmt TtlFeeAmt USD 0 2026-11-09 S-3 2026-11-10 0001104659-26-125314
ffd TtlOfferingAmt TtlOfferingAmt USD 200.00M 2026-11-09 S-3 2026-11-10 0001104659-26-125314
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-11-09 S-3 2026-11-10 0001104659-26-125314
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-11-09 S-3 2026-11-10 0001104659-26-125314
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 762,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 691,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap AccretionExpense Accretion Expense USD 276,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 1,000 2015-09-30 2015 Q3 10-Q 2015-11-06 0001564590-15-009779
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 641,000 2023-06-30 2023 Q2 10-Q 2023-08-08 0000950170-23-039820
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 2.28M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap AccruedRoyaltiesCurrentAndNoncurrent Accrued Royalties USD 32.09M 2023-06-30 2023 Q2 10-Q 2023-08-08 0000950170-23-039820
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 1.56M 2015-09-30 2015 Q3 10-Q 2015-11-06 0001564590-15-009779
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 213,000 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 7.34M 2014-09-30 2014 Q3 10-Q 2014-11-12 0001564590-14-005463
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 2.00B 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap AdjustmentForAmortization Amortization USD 2.77M 2012-08-22 2012-12-31 2014 FY 10-K 2015-02-26 0001564590-15-001038
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 457,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 134,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 1.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 58,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 107.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap AssetRetirementObligation Asset Retirement Obligation USD 953,000 2021-12-31 2021 FY 10-K 2022-02-28 0001564590-22-007633
us-gaap AssetRetirementObligationAccretionExpense Asset Retirement Obligation, Accretion Expense USD 87,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001564590-22-007633
us-gaap AssetRetirementObligationLiabilitiesIncurred Asset Retirement Obligation, Liabilities Incurred USD 88,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-26 0001564590-19-004275
us-gaap Assets Assets USD 18.61M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap AssetsCurrent Assets, Current USD 11.31M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 190,000 2022-03-31 2022 Q1 10-Q 2022-05-05 0001564590-22-018253
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 95.39M 2015-03-31 2015 Q1 10-Q 2015-05-11 0001564590-15-003950
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 164.64M 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003390
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 2,000 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003390
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 153,000 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003390
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 164.79M 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003390
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 279.80M 2015-09-30 2015 Q3 10-Q 2015-11-06 0001564590-15-009779
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 0 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-219482
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 0 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-219482
us-gaap AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value USD 279.80M 2015-09-30 2015 Q3 10-Q 2015-11-06 0001564590-15-009779
us-gaap AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost USD 9.62M 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-346885
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 9.62M 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-346885
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 9.61M 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-346885
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 9.61M 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-346885
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0000950170-25-072040
us-gaap CapitalLeaseObligations Capital Lease Obligations USD 738,000 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007027
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 490,000 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007027
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009854
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 248,000 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007027
us-gaap CapitalLeasesFutureMinimumPaymentsDue Capital Leases, Future Minimum Payments Due USD 803,000 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007027
us-gaap CapitalLeasesFutureMinimumPaymentsDueCurrent Capital Leases, Future Minimum Payments Due, Next Twelve Months USD 540,000 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007027
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFiveYears Capital Leases, Future Minimum Payments Due in Five Years USD 0 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007027
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFourYears Capital Leases, Future Minimum Payments Due in Four Years USD 0 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007027
us-gaap CapitalLeasesFutureMinimumPaymentsDueInThreeYears Capital Leases, Future Minimum Payments Due in Three Years USD 29,000 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007027
us-gaap CapitalLeasesFutureMinimumPaymentsDueInTwoYears Capital Leases, Future Minimum Payments Due in Two Years USD 234,000 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007027
us-gaap CapitalLeasesFutureMinimumPaymentsDueThereafter Capital Leases, Future Minimum Payments Due Thereafter USD 0 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007027
us-gaap CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments Capital Leases, Future Minimum Payments, Interest Included in Payments USD 65,000 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007027
us-gaap CapitalUnitsAuthorized Capital Units, Authorized shares 520.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap Cash Cash GBP 0 2017-12-31 2018 FY 10-K 2019-02-26 0001564590-19-004275
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 4.05M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 31.25M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003390
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 9.90M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 4.05M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -4.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 901,812 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 10.19M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 10.19M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap CommonStockValue Common Stock, Value, Issued USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap CommonStockValueOutstanding Common Stock, Value, Outstanding USD 2.20M 2013-12-31 2014 FY 10-K 2015-02-26 0001564590-15-001038
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -11.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -9.08M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-11 0001564590-15-003950
us-gaap ContractualObligation Contractual Obligation USD 16.39M 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003390
us-gaap ContractualObligationDueAfterFifthYear Contractual Obligation, to be Paid, after Year Five USD 12.20M 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003390
us-gaap ContractualObligationDueInFifthYear Contractual Obligation, to be Paid, Year Five USD 996,000 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003390
us-gaap ContractualObligationDueInFourthYear Contractual Obligation, to be Paid, Year Four USD 966,000 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003390
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 372,000 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003390
us-gaap ContractualObligationDueInSecondYear Contractual Obligation, to be Paid, Year Two USD 911,000 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003390
us-gaap ContractualObligationDueInThirdYear Contractual Obligation, to be Paid, Year Three USD 938,000 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003390
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 513,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 513,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 605,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod Contract with Customer, Performance Obligation Satisfied in Previous Period USD 200,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 12.30M 2014-12-31 2014 FY 10-K 2015-02-26 0001564590-15-001038
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 580,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap CostsAndExpenses Costs and Expenses USD 13.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD 364,000 2018-12-31 2020 Q1 10-Q 2020-05-06 0001564590-20-021960
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 28,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 31,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 3,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap DebtInstrumentIncreaseAccruedInterest Debt Instrument, Increase, Accrued Interest USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-09 0001564590-17-003792
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap DeferredIncomeAddition DeferredIncomeAddition USD 38.17M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-037644
us-gaap DeferredIncomeCurrent Deferred Income, Current USD 775,000 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-346885
us-gaap DeferredIncomeNoncurrent Deferred Income, Noncurrent USD 77.00M 2022-12-31 2022 FY 10-K 2023-02-08 0000950170-23-002185
us-gaap DeferredIncomeRevenueRecognized DeferredIncomeRevenueRecognized USD 7.78M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-037644
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap DeferredRevenue Deferred Revenue USD 1.00M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001193125-25-276219
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-346885
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 356.70M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 1.66M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 289.52M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 1.20B 2024-12-31 2024 FY 10-K 2025-03-07 0000950170-25-035507
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration USD 15.30M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 1.05B 2021-12-31 2021 FY 10-K 2022-02-28 0001564590-22-007633
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 10.09M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 8.35M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 106.90M 2022-12-31 2022 FY 10-K 2023-02-08 0000950170-23-002185
us-gaap DeferredTaxAssetsTaxDeferredExpense Deferred Tax Assets, Tax Deferred Expense USD 41.95M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 99,000 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Legal Settlements USD 1.38M 2018-12-31 2018 FY 10-K 2019-02-26 0001564590-19-004275
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 355.04M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap DeferredTaxExpenseFromStockOptionsExercised Deferred Tax Expense from Stock Options Exercised USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 1.66M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 0 2021-12-31 2021 FY 10-K 2022-02-28 0001564590-22-007633
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.06 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.5 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap Depreciation Depreciation USD 400,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 46,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap DilutiveSecurities Dilutive Securities, Effect on Basic Earnings Per Share USD 0 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0000950170-23-039820
us-gaap DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent Disposal Group, Including Discontinued Operation, Assets, Noncurrent USD 51.43M 2022-03-31 2022 Q1 10-Q 2022-05-05 0001564590-22-018253
us-gaap DisposalGroupIncludingDiscontinuedOperationConsideration Disposal Group, Including Discontinued Operation, Consideration USD 94.80M 2022-04-04 2023 FY 10-K 2024-03-28 0000950170-24-037644
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets Disposal Group, Including Discontinued Operation, Other Assets, Current USD 190,000 2022-12-31 2023 FY 10-K 2024-03-28 0000950170-24-037644
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities Disposal Group, Including Discontinued Operation, Other Liabilities, Current USD 39,000 2022-12-31 2022 FY 10-K 2023-02-08 0000950170-23-002185
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent USD 39,000 2022-12-31 2023 FY 10-K 2024-03-28 0000950170-24-037644
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent USD 960,000 2022-03-31 2022 Q1 10-Q 2022-05-05 0001564590-22-018253
us-gaap DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current USD 190,000 2022-12-31 2022 FY 10-K 2023-02-08 0000950170-23-002185
us-gaap DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent USD 44.30M 2022-12-31 2023 FY 10-K 2024-03-28 0000950170-24-037644
us-gaap DisposalGroupNotDiscontinuedOperationGainLossOnDisposal Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-037644
us-gaap DividendsCommonStockStock Dividends, Common Stock, Stock USD 400,000 2023-10-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.76 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.87 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0001564590-22-018253
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.76 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.436 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007027
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007027
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009854
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.162 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.268 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003390
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 471,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 66,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 66,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-07 0000950170-25-035507
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 2.67M 2025-03-31 2025 Q1 10-Q 2025-05-15 0000950170-25-072040
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 0 2025-03-31 2025 Q1 10-Q 2025-05-15 0000950170-25-072040
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 947,000 2025-03-31 2025 Q1 10-Q 2025-05-15 0000950170-25-072040
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 0 2025-03-31 2025 Q1 10-Q 2025-05-15 0000950170-25-072040
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 0 2025-03-31 2025 Q1 10-Q 2025-05-15 0000950170-25-072040
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 436,000 2025-03-31 2025 Q1 10-Q 2025-05-15 0000950170-25-072040
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 1.28M 2025-03-31 2025 Q1 10-Q 2025-05-15 0000950170-25-072040
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 151,000 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041368
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 280,000 2025-03-31 2025 Q1 10-Q 2025-05-15 0000950170-25-072040
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 250,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 240,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.104 2025-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-219482
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003390
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD 50.24M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-08 0000950170-23-002185
us-gaap GainLossOnSaleOfProperties Gain (Loss) on Sale of Properties USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-037644
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -21,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001564590-22-007633
us-gaap GainLossOnSalesOfAssetsAndAssetImpairmentCharges Gain (Loss) on Sale of Assets and Asset Impairment Charges USD 50.24M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-28 0000950170-24-037644
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 1.17M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 10.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 32.74M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -11.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -18,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares -3.49 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-06 0001564590-18-027095
us-gaap IncomeTaxesPaid Income Taxes Paid USD 190,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -14.26M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 496,000 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007027
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 6.87M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 17,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 3,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -103,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 635,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -562,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -203,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 59,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-346885
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD -800,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap IncreaseDecreaseInIncomeTaxes Increase (Decrease) in Income Taxes USD -92,000 2014-01-01 2014-09-30 2015 Q3 10-Q 2015-11-06 0001564590-15-009779
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -10.65M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -809,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 1.10M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-09 0001564590-17-023005
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -1.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD 121,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -113,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 1,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -110,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-346885
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 25,000 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-06 0001564590-15-009779
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -169,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0000950170-23-039820
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 1.20M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003390
us-gaap IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible Increase in Unrecognized Tax Benefits is Reasonably Possible USD 1.10M 2016-09-30 2016 Q3 10-Q 2016-11-04 0001564590-16-027509
us-gaap InterestAndOtherIncome Interest and Other Income USD 696,000 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-06 0001564590-15-009779
us-gaap InterestExpense Interest Expense USD 1.02M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-346885
us-gaap InterestIncomeOperating Interest Income, Operating USD 132,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-346885
us-gaap InterestIncomeOther Interest Income, Other USD 125,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-26 0001564590-15-001038
us-gaap InterestIncomeRelatedParty Interest Income, Related Party USD 2,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-09 0001564590-17-003792
us-gaap InterestPaidCapitalized Interest Paid, Capitalized, Investing Activities USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009854
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 421,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap InterestPayableCurrent Interest Payable, Current USD 763,000 2023-09-30 2023 Q3 10-Q 2023-11-01 0000950170-23-057147
us-gaap InterestReceivable Interest Receivable USD 100,000 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-125389
us-gaap InventoryNet Inventory, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap InvestmentIncomeAmortizationOfPremium Investment Income, Amortization of Premium USD 358,000 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-11 0001564590-15-003950
us-gaap InvestmentIncomeInterestAndDividend Investment Income, Interest and Dividend USD 199,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 71,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 12.52M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 3.98M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 414,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 2.12M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 2.06M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.94M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 650,000 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041368
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 2.95M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap Liabilities Liabilities USD 56.51M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 18.61M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap LiabilitiesCurrent Liabilities, Current USD 6.57M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 13.00M 2018-12-31 2018 FY 10-K 2019-02-26 0001564590-19-004275
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 252,000 2022-03-31 2022 Q1 10-Q 2022-05-05 0001564590-22-018253
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent USD 8.33M 2022-03-31 2022 Q1 10-Q 2022-05-05 0001564590-22-018253
us-gaap LicenseCosts License Costs (Deprecated 2018-01-31) USD 4.50M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-09 0001564590-17-023005
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 8.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 296.01M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011469
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -5.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -249.92M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011469
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -7.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -34.82M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011469
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -11.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1 New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets (Deprecated 2020-01-31) USD 400,000 2018-07-31 2018 FY 10-K 2019-02-26 0001564590-19-004275
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 1.08M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003390
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -148,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap OperatingExpenses Operating Expenses USD 148.62M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0000950170-23-039820
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -11.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap OperatingLeaseCost Operating Lease, Cost USD 586,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 4.13M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 9.57M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.08M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 8.48M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap OperatingLeasePayments Operating Lease, Payments USD 655,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 6.49M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 10.16M 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007027
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 1.11M 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007027
us-gaap OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals USD 18,000 2016-12-31 2016 FY 10-K 2017-03-09 0001564590-17-003792
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 1.38M 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007027
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 1.34M 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007027
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 1.55M 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007027
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 1.67M 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007027
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 3.12M 2018-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007027
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 375,000 2016-09-30 2016 Q3 10-Q 2016-11-04 0001564590-16-027509
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 2.20M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009854
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.088 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 20.60M 2014-12-31 2014 FY 10-K 2015-02-26 0001564590-15-001038
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 330,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap OtherAssetsCurrent Other Assets, Current USD 705,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 762,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 151,000 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-06 0001564590-15-009779
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -2,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 3.69M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 1.90M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap OtherLongTermDebtCurrent Other Long-term Debt, Current USD 100,000 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-346885
us-gaap OtherNoncashExpense Other Noncash Expense USD 750,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-26 0001564590-15-001038
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -164,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -14,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 890,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-346885
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009854
us-gaap PaymentsForRestructuring Payments for Restructuring USD 1.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap PaymentsForRoyalties Payments for Royalties USD 420,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 19,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-26 0001564590-15-001038
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-11 0000950170-25-106550
us-gaap PaymentsToAcquireLeaseReceivables Payments to Acquire Lease Receivables USD 31.00M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-08 0000950170-23-002185
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 9.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-346885
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 20.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2015-09-30 2015 Q3 10-Q 2015-11-06 0001564590-15-009779
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 16.05M 2022-09-30 2022 Q3 10-Q 2022-11-08 0000950170-22-023248
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 800,000 2017-03-31 2017 Q1 10-Q 2017-05-04 0001564590-17-008828
us-gaap PrepaidRoyalties Prepaid Royalties USD 32.73M 2023-06-30 2023 Q2 10-Q 2023-08-08 0000950170-23-039820
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-037644
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 8.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-09 0001564590-17-003792
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 0 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001564590-19-030426
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 4,000 2012-08-22 2012-12-31 2014 FY 10-K 2015-02-26 0001564590-15-001038
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 15.00M 2025-05-14 2025 Q1 10-Q 2025-05-15 0000950170-25-072040
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 63.31M 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-09 0001564590-19-017599
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD -1,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD 37,000 2014-01-01 2014-03-31 2015 Q1 10-Q 2015-05-11 0001564590-15-003950
us-gaap ProceedsFromRoyaltiesReceived Proceeds from Royalties Received USD 31.00M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-08 0000950170-23-002185
us-gaap ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments Proceeds from Sale, Maturity and Collection of Short-term Investments USD 3.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ProceedsFromSaleOfMachineryAndEquipment Proceeds from Sale of Machinery and Equipment USD 94.77M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-08 0000950170-23-002185
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 393,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 12.51M 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-09 0001564590-19-017599
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 250,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-04 0001564590-16-027509
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 13,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -11.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 286,000 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 38,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits Property Subject to or Available for Operating Lease, Number of Units Property 3 2014-12-31 2014 FY 10-K 2015-02-26 0001564590-15-001038
us-gaap RepaymentOfNotesReceivableFromRelatedParties Repayment of Notes Receivable from Related Parties USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-09 0001564590-17-003792
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 98,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-09 0001564590-19-017599
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 2.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 20.89M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-06 0001564590-15-009779
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 4.50M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-06 0001564590-15-009779
us-gaap RestrictedCash Restricted Cash USD 1.30M 2022-09-30 2022 Q3 10-Q 2022-11-08 0000950170-22-023248
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 1.40M 2018-09-30 2018 Q3 10-Q 2018-11-06 0001564590-18-027095
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 194,000 2018-09-30 2018 Q3 10-Q 2018-11-06 0001564590-18-027095
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 1.20M 2018-09-30 2018 Q3 10-Q 2018-11-06 0001564590-18-027095
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 146,000 2024-12-31 2024 FY 10-K 2025-03-07 0000950170-25-035507
us-gaap RestrictedStockValueSharesIssuedNetOfTaxWithholdings Restricted Stock, Value, Shares Issued Net of Tax Withholdings USD -1,000 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.23 2026-06-01 2026-06-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap RestructuringCharges Restructuring Charges USD 767,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap RestructuringReserve Restructuring Reserve USD 594,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 100,000 2022-09-30 2022 Q3 10-Q 2022-11-08 0000950170-22-023248
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -2.03B 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 2.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 120.77M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 500,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap Revenues Revenues USD 1.15M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-346885
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 4.80M 2022-04-04 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 50.80M 2022-04-04 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap SettlementOfAssetRetirementObligationsThroughNoncashPaymentsAmount Settlement of Asset Retirement Obligations Through Noncash Payments, Amount USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-01 0001564590-21-009854
us-gaap SeveranceCosts1 Severance Costs USD 800,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 1.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 66,153 2014-01-04 2014-09-30 2014 Q3 10-Q 2014-11-12 0001564590-14-005463
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 8.593 2014-01-04 2014-09-30 2014 Q3 10-Q 2014-11-12 0001564590-14-005463
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 966,190 2014-09-30 2014 Q3 10-Q 2014-11-12 0001564590-14-005463
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 3.561 2014-09-30 2014 Q3 10-Q 2014-11-12 0001564590-14-005463
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 36,058 2014-01-04 2014-09-30 2014 Q3 10-Q 2014-11-12 0001564590-14-005463
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 0.404 2014-01-04 2014-09-30 2014 Q3 10-Q 2014-11-12 0001564590-14-005463
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.142 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.04 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 30.00M 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011469
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 64,476 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 190.54 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 100,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-28 0000950170-24-037644
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 7,814 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 16,500 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 9.2 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 23,000 2025-12-31 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 64,476 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 190.54 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 85.25M 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011469
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 64,476 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 190.54 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 2.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent pure 1 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-06 0001564590-15-009779
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 20.02 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011469
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 202.18 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 34.37 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011469
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 6.61 2025-05-31 2026 Q2 10-Q 2026-08-12 0001193125-26-346885
us-gaap ShortTermInvestments Short-term Investments USD 5.86M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 42,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -37.90M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance (Deprecated 2020-01-31) USD 339.22M 2018-12-31 2020 Q1 10-Q 2020-05-06 0001564590-20-021960
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.769 2014-07-08 2014-07-09 2015 FY 10-K 2016-03-04 0001564590-16-014061
us-gaap StockholdersEquityNoteSubscriptionsReceivable Stockholders' Equity Note, Subscriptions Receivable USD 335,000 2013-12-31 2014 FY 10-K 2015-02-26 0001564590-15-001038
us-gaap StockIssued1 Stock Issued USD 1.19M 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001564590-20-007027
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 59,761 2014-09-01 2014-09-30 2017 Q3 10-Q 2017-11-09 0001564590-17-023005
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 834,237 2025-05-31 2026 Q2 10-Q 2026-08-12 0001193125-26-346885
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 59,761 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-26 0001564590-15-001038
us-gaap StockIssuedDuringPeriodSharesPeriodIncreaseDecrease Stock Issued During Period, Shares, Period Increase (Decrease) shares 1.30M 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-26 0001564590-15-001038
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures shares 281,826 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-26 0001564590-15-001038
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensation Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture shares 644,710 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-26 0001564590-15-001038
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 15,989 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-28 0000950170-24-037644
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 74.57M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-09 0001564590-17-003792
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 160,000 2019-07-01 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041368
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 56.46M 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-26 0001564590-15-001038
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 865,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 750,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-26 0001564590-15-001038
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 70,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-09 0001564590-17-003792
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 12,000 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 439,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003390
us-gaap SupplementalUnemploymentBenefitsSeveranceBenefits Supplemental Unemployment Benefits, Severance Benefits USD 800,000 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-346885
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 1,000 2015-03-31 2015 Q1 10-Q 2015-05-11 0001564590-15-003950
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 61.09M 2013-12-31 2014 FY 10-K 2015-02-26 0001564590-15-001038
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 102.77M 2013-12-31 2014 FY 10-K 2015-02-26 0001564590-15-001038
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2014-12-31 2014 FY 10-K 2015-02-26 0001564590-15-001038
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2014-12-31 2014 FY 10-K 2015-02-26 0001564590-15-001038
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -11,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-12 0001564590-14-005463
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 38.07M 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 133,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD 800,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001564590-18-003390
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2021-12-31 2021 FY 10-K 2022-02-28 0001564590-22-007633
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 13.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001193125-26-108361
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 134,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 14.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 100.73M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0001564590-22-018253
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 14.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125192

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →